Research Analysts Issue Forecasts for TSE:BHC Q1 Earnings

Bausch Health Companies Inc. (TSE:BHC) – Equities researchers at Zacks Research increased their Q1 2025 earnings per share (EPS) estimates for Bausch Health Companies in a research report issued on Monday, January 20th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $1.25 for the quarter, up from their prior forecast of $1.22. The consensus estimate for Bausch Health Companies’ current full-year earnings is $5.55 per share. Zacks Research also issued estimates for Bausch Health Companies’ Q2 2025 earnings at $1.49 EPS, Q1 2026 earnings at $1.58 EPS, Q2 2026 earnings at $1.65 EPS and Q3 2026 earnings at $1.98 EPS.

Separately, Evercore ISI raised Bausch Health Companies to a “hold” rating in a research report on Tuesday, October 15th.

Bausch Health Companies Trading Up 3.8 %

Shares of Bausch Health Companies stock opened at C$11.12 on Wednesday. Bausch Health Companies has a 1 year low of C$5.45 and a 1 year high of C$15.43. The company has a debt-to-equity ratio of 7,583.76, a current ratio of 1.19 and a quick ratio of 0.58. The business has a 50 day moving average price of C$11.24 and a 200 day moving average price of C$10.33. The company has a market capitalization of C$4.08 billion, a P/E ratio of -6.35, a P/E/G ratio of 0.21 and a beta of 0.77.

Bausch Health Companies (TSE:BHC) last posted its earnings results on Wednesday, October 30th. The company reported C$1.53 earnings per share for the quarter, beating the consensus estimate of C$1.43 by C$0.10. Bausch Health Companies had a negative net margin of 5.12% and a negative return on equity of 2,304.54%. The firm had revenue of C$3.42 billion during the quarter, compared to the consensus estimate of C$3.36 billion.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.